Come up with a name for your new list and we'll add to it:
Mills Pharmaceuticals was acquired by
Galena Biopharma on January 13, 2014.
Mills Pharmaceuticals owns the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide for the treatment of Essential Thrombocythemia (ET). GALE-401 (Ana…